Abstract: Abstract Background Clinical nurses working in an acute neurosurgery ward and researchers conducted research using the research process model with the aim to improve nursing competency, nursing autonomy, work motivation, ethics, and actual nursing care content. The research clarified: (a) how clinical nurses in the neurosurgical ward changed and the PubDate: 2021-10-29T00:00:00Z
Abstract: Abstract Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the HTT gene. The motor, cognitive and psychiatric features of HD are progressive and complex, requiring specialised care by medical, nursing and allied health care professionals. This paper discusses the role of the PubDate: 2021-10-29T00:00:00Z
Abstract: Abstract Lewy Body Dementia (LBD) is an umbrella term for two dementia subtypes Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD) (Armstrong et al., 2020a; Larrson et al., 2019). Despite being the second most common type of dementia after Alzheimer’s Disease (AD), 1 in 3 cases of LBD PubDate: 2021-10-29T00:00:00Z
Abstract: Vasopressin or anti-diuretic hormone (ADH) is a nonapeptide that is synthesized in the hypothalamus and plays an important role in the control of the body’s osmotic balance, blood pressure regulation and kidney function. ADH induces expression of water transport proteins in the late distal tubule and collecting duct to increase PubDate: 2021-10-29T00:00:00Z
Abstract: Abstract Introduction: We describe an Australian experience of infusional bevacizumab for vestibular schwannoma (VS) in neurofibromatosis type 2 patients, with specific focus on 3-dimensional tumour volume and audiometry. Method: Data was pooled from patients with symptomatic or progressive VS from 2009 to April 2018. Tumours were assessed as total volume PubDate: 2021-05-01T00:00:00Z
Abstract: Abstract: Parkinson’s disease is the second most common neurological disorder after dementia in Australia (Deloitte, 2015). The complexities of caring for a person with Parkinson’s disease highlights the need for Parkinson’s disease and movement disorder nurse specialists (PDMDNS) (Bramble, Carroll, & Rossiter, 2018). The Australasian Neuroscience Nurses Association’s (ANNA) Movement PubDate: 2021-05-01T00:00:00Z
Open Access journal
[23 journals]
